About the journal
Diabetes Obesity and Metabolism is a journal published by Wiley in United Kingdom. It is listed in MEDLINE according to the sources read. Declared publication charge: 4,940 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Wiley
- ISSN
- 1462-8902 · 1463-1326
- Country
- United Kingdom
- Access
- Not open access / not declared
- Declared publication charge
- 4,940 USD
- Declared peer-review model
- peer_review
- Official website
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1463-1326
Index listings
- MEDLINE · 1999-01-01
- Indexing
- MEDLINE
- APC
- 4,940 USD
- Declared review time (DOAJ)
- —
- Actual review time (measured)
- 76 days received→accepted — computed from PubMed (n=96)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
7787
Last recorded publication year
2026
h-index
185
i10-index
4053
From OpenAlex open data (CC0).
Editorial & policy5
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 94%
- ORCID iDs in current deposits
- 94%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
Identity & continuity3
- Alternate titles
- Diabetes Obes MetabDiabetes, obesity and metabolism
- Source type
- journal
- NLM unique ID (PubMed)
- 100883645
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Diabetes Treatment and Management
- Diabetes Treatment and Management
- Diabetes Treatment and Management
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Management and Research
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
Show all subjects (75)
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Pancreatic function and diabetes
- Pancreatic function and diabetes
- Pharmacology and Obesity Treatment
- Metabolism, Diabetes, and Cancer
- Metabolism, Diabetes, and Cancer
- Bariatric Surgery and Outcomes
- Pancreatic function and diabetes
- Bariatric Surgery and Outcomes
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Diabetes and associated disorders
- Diabetes and associated disorders
- Chronic Kidney Disease and Diabetes
- Diabetes and associated disorders
- Diabetes Management and Education
- Diet and metabolism studies
- Diet and metabolism studies
- Adipokines, Inflammation, and Metabolic Diseases
- Pharmacology and Obesity Treatment
- Heart Failure Treatment and Management
- Pharmacology and Obesity Treatment
- Adipokines, Inflammation, and Metabolic Diseases
- Adipokines, Inflammation, and Metabolic Diseases
- Chronic Kidney Disease and Diabetes
- Chronic Kidney Disease and Diabetes
- Regulation of Appetite and Obesity
- Regulation of Appetite and Obesity
- Bariatric Surgery and Outcomes
- Regulation of Appetite and Obesity
- Liver Disease Diagnosis and Treatment
- Liver Disease Diagnosis and Treatment
- Diabetes Management and Education
- Diabetes Management and Education
- Adipose Tissue and Metabolism
- Adipose Tissue and Metabolism
- Liver Disease Diagnosis and Treatment
- Cardiovascular Function and Risk Factors
- Cardiovascular Function and Risk Factors
- Obesity, Physical Activity, Diet
- Metabolism, Diabetes, and Cancer
- Peroxisome Proliferator-Activated Receptors
- Peroxisome Proliferator-Activated Receptors
- Heart Failure Treatment and Management
- Heart Failure Treatment and Management
- Lipoproteins and Cardiovascular Health
- Lipoproteins and Cardiovascular Health
- Lipoproteins and Cardiovascular Health
- Cardiovascular Function and Risk Factors
- Blood Pressure and Hypertension Studies
- Blood Pressure and Hypertension Studies
- Acute Kidney Injury Research
- Blood Pressure and Hypertension Studies
- Adipose Tissue and Metabolism
- Health Systems, Economic Evaluations, Quality of Life
- Genetic Associations and Epidemiology
- Gestational Diabetes Research and Management
- Nutritional Studies and Diet
- Nutritional Studies and Diet
- Cardiovascular Disease and Adiposity
- Neuropeptides and Animal Physiology
- Neuropeptides and Animal Physiology
- Cardiovascular Disease and Adiposity
- Gestational Diabetes Research and Management
- Peroxisome Proliferator-Activated Receptors
- Gestational Diabetes Research and Management
- Natural Antidiabetic Agents Studies
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ